JMJD3 overexpression potently inhibited the in vivo repopulation of two granulocytic subtypes of AML cells (Fig. 2e, f and Supplementary Fig. 1b), and greatly elongated the recipients’ survival (Fig. 2g). The gene discussed is KDM6B; the disease is acute myeloid leukemia.